4.0.0.0 Ref­er­ences

1. Chi­ang JL, Maahs DM, Gar­vey KC, et al. Type 1 di­a­betes in chil­dren and ado­les­cents: a po­si­tion state­mentby the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2018;41:2026–2044
2. Ar­sla­ni­an S, Bacha F, Grey M, Mar­cus MD,White NH, Zeitler P. Eval­u­a­tion and man­age­ment of youth-‍onset type 2 di­a­betes: a po­si­tion state­mentby the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2018;41:2648–2668
3. Nadeau KJ, An­der­son BJ, Berg EG, et al. Youth-‍onset type 2 di­a­betes con­sen­sus re­port: cur­rent sta­tus, chal­lenges, and pri­or­i­ties. Di­a­betes Care 2016;39:1635–1642
4. Mayer-‍Davis EJ, Lawrence JM, Dabe­lea D, et al.; SEARCH for Di­a­betes in Youth Study. In­ci­dence trends of type 1 and type 2 di­a­betes among youths, 2002–2012. N Engl J Med 2017; 376:1419–1429
5. Thomas NJ, Jones SE, Wee­don MN, Shields BM, Oram RA, Hat­ter­s­ley AT. Fre­quen­cy and phe­no­type of type 1 di­a­betes in the first six decades of life: a cross-sec­tional, ge­net­ically stratified sur­vival anal­y­sis from UK Biobank. Lancet Di­a­betes En­docrinol 2018;6:122–129
6. Barnea-‍Goraly N, Raman M, Mazai­ka P, et al.; Di­a­betes Re­search in Chil­dren Net­work (Direc-‍ Net). Al­ter­ations in white mat­ter struc­ture in young chil­dren with type 1 di­a­betes. Di­a­betes Care 2014;37:332–340
7. Cameron FJ, Scratch SE, Nade­baum C, et al.; DKA Brain In­jury Study Group. Neu­ro­log­i­cal con­se­quences of di­a­bet­ic ke­toaci­do­sis at ini­tial pre­sentation of type 1 di­a­betes in a prospec­tive co­hort study of chil­dren. Di­a­betes Care 2014;37: 1554–1562
8. Markowitz JT, Gar­vey KC, Laf­fel LMB. Developmen­tal changes in the roles of pa­tients and fam­i­lies in type 1 di­a­betes man­age­ment. Curr Di­a­betes Rev 2015;11:231–238
9. Driscoll KA, Volken­ing LK, Haro H, et al. Are chil­dren with type 1 di­a­betes safe at school? Ex­am­in­ing par­ent per­cep­tions. Pe­di­atr Di­a­betes 2015;16:613–620
10. Mehta SN, Volken­ing LK, An­der­son BJ, et al.; Fam­i­ly Man­age­ment of Child­hood Di­a­betes Study Steer­ing Com­mit­tee. Di­etary be­hav­iors pre­dict glycemic con­trol in youth with type 1 di­a­betes. Di­a­betes Care 2008;31:1318–1320
11. Rid­dell MC, Gallen IW, Smart CE, et al. Ex­er­cise man­age­ment in type 1 di­a­betes: a con­sen­sus state­ment. Lancet Di­a­betes En­docrinol 2017;5:377–390
12. Col­berg SR, Sigal RJ, Yard­ley JE, et al. Phys­i­cal ac­tiv­i­ty/ex­er­cise and di­a­betes: a po­si­tion state­ment of the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2016;39:2065–2079
13. Robert­son K, Adolf­s­son P, Schein­er G, Hanas R, Rid­dell MC. Ex­er­cise in chil­dren and ado­les­cents with di­a­betes. Pe­di­atr Di­a­betes 2009;10 (Suppl. 12):154–168
14. U.S. De­part­ment of Health and Human Ser­vices. 2008 phys­i­cal ac­tiv­i­ty guide­lines for Amer­i­cans: index [In­ter­net]. Avail­able from https:// health.gov/paguide­lines/guide­lines/default. aspx. Ac­cessed 16 Oc­to­ber 2018
15. Tsa­likian E, Koll­man C, Tam­bor­lane WB, et al.; Di­a­betes Re­search in Chil­dren Net­work (Di­rec­Net) Study Group. Pre­ven­tion of hy­po­glycemia dur­ing ex­er­cise in chil­dren with type 1 di­a­betes by sus­pending basal in­sulin. Di­a­betes Care 2006;29:2200–2204
16. Ta­plin CE, Cobry E, Mess­er L, Mc­Fann K, Chase HP, Fiallo-‍Scharer R. Pre­vent­ing post-‍ex­er­cise noc­tur­nal hy­po­glycemia in chil­dren with type 1 di­a­betes. J Pe­di­atr 2010;157: 784–788.e1
17. Rid­dell MC, Mil­liken J. Pre­vent­ing ex­er­cise-induced hy­po­glycemia in type 1 di­a­betes using real-‍time con­tin­u­ous glu­cose mon­i­tor­ing and a new car­bo­hy­drate in­take al­go­rithm: an ob­ser­va­tion­al field study. Di­a­betes Tech­nol Ther 2011; 13:819–825
18. Francesca­to MP, Stel G, Sten­ner E, Geat M. Pro­longed ex­er­cise in type 1 di­a­betes: per­for­mance of a cus­tomiz­able al­go­rithm to es­ti­mate the car­bo­hy­drate sup­ple­ments to min­i­mize glycemic imbal­ances. PLoS One 2015;10:e0125220
19. Adolf­s­son P, Matts­son S, Jen­dle J. Eval­u­a­tion of glu­cose con­trol when a new strat­e­gy of in­creased car­bo­hy­drate sup­ply is im­ple­mented dur­ing pro­longed phys­i­cal ex­er­cise in type 1 di­a­betes. Eur J Appl Phys­i­ol 2015;115:2599–2607
20. Baker LB, Rollo I, Stein KW, Jeuk­endrup AE. Acute ef­fects of car­bo­hy­drate sup­ple­men­ta­tion on in­ter­mit­tent sports per­for­mance. Nu­tri­ents 2015;7:5733–5763
21. Re­don­do MJ, Lib­man I, Cheng P, et al.; Pe­di­atric Di­a­betes Con­sor­tium. Racial/eth­nic mi­nor­i­ty youth with re­cent-‍onset type 1 di­a­betes have poor prog­nos­tic fac­tors. Di­a­betes Care 2018;41:1017–1024
22. Liu LL, Lawrence JM, Davis C, et al.; SEARCH for Di­a­betes in Youth Study Group. Preva­lence of over­weight and obe­si­ty in youth with di­a­betes in USA: the SEARCH for Di­a­betes in Youth study. Pe­di­atr Di­a­betes 2010;11:4–11
23. Du­Bose SN, Her­mann JM, Tam­bor­lane WV, et al.; Type 1 Di­a­betes Ex­change Clin­ic Net­work and Di­a­betes Prospec­tive Fol­low-‍up Reg­istry. Obe­si­ty in youth with type 1 di­a­betes in Ger­many, Aus­tria, and the Unit­ed States. J Pe­di­atr 2015;167:627–632.e4
24. Corbin KD, Driscoll KA, Prat­ley RE, Smith SR, Maahs DM, Mayer-‍Davis EJ; Ad­van­cing Care for Type 1 Di­a­betes and Obe­si­ty Net­work (ACT1ON). Obe­si­ty in type 1 di­a­betes: patho­phys­i­ol­o­gy, clin­i­cal im­pact, and mech­a­nisms. En­docr Rev 2018;39:629–663
25. Re­don­do MJ, Fos­ter NC, Lib­man IM, et al. Preva­lence of car­dio­vas­cu­lar risk fac­tors in youth with type 1 di­a­betes and el­e­vat­ed body mass index. Acta Di­a­betol 2016;53:271–277
26. Jack­son CC, Al­banese-‍O’Neill A, But­ler KL, et al. Di­a­betes care in the school set­ting: a po­si­tion state­ment of the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2015;38:1958–1963
27. Simine­r­io LM, Al­banese-‍O’Neill A, Chi­ang JL, et al.; Amer­i­can Di­a­betes As­so­ci­a­tion. Care of young chil­dren with di­a­betes in the child care set­ting: a po­si­tion state­ment of the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2014;37:2834–2842
28. Corathers SD, Kich­ler J, Jones N-HY, et al. Im­prov­ing de­pres­sion screen­ing for ado­les­cents with type 1 di­a­betes. Pe­di­atrics. 2013;132: e1395–e1402
29. Hood KK, Beavers DP, Yi-‍Fra­zier J, et al. Psychoso­cial bur­den and glycemic con­trol dur­ing the first 6 years of di­a­betes: re­sults from the SEARCH for Di­a­betes in Youth study. J Ado­lesc Health 2014;55:498–504
30. Ducat L, Philip­son LH, An­der­son BJ. The men­tal health co­mor­bidities of di­a­betes. JAMA 2014;312:691–692
31. Hag­ger V, Hen­drieckx C, Sturt J, Skin­ner TC, Speight J. Di­a­betes dis­tress among ado­les­cents with type 1 di­a­betes: a sys­tematic re­view. Curr Diab Rep 2016;16:9
32. An­der­son BJ, Laf­fel LM, Domenger C, et al. Fac­tors as­so­ci­at­ed with di­a­betes-‍specific health-‍re­lat­ed qual­i­ty of life in youth with type 1 di­a­betes: the glob­al TEENs study [pub­lished cor­rection ap­pears in Di­a­betes Care 2018;41:640]. Di­a­betes Care 2017;40: 1002–1009
33. Hilliard ME, De Wit M, Wasser­man RM, et al. Screen­ing and sup­port for emo­tion­al bur­dens of youth with type 1 di­a­betes: strate­gies for di­a­betes care pro­viders. Pe­di­atr Di­a­betes 2018; 19:534–543
34. Shapiro JB, Vesco AT, Weil LEG, Evans MA, Hood KK, Weissberg-‍Benchell J. Psy­cho­me­t­ric prop­er­ties of the Prob­lem Areas in Di­a­betes: Teen and Par­ent of Teen ver­sions. J Pe­di­atr Psy­chol 2018;43:561–571
35. Young-‍Hyman D, de Groot M, Hill-‍Brig­gs F, Gon­za­lez JS, Hood K, Pey­rot M. Psychoso­cial care for peo­ple with di­a­betes: a po­si­tion state­ment of the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2016;39:2126–2140
36. Katz ML, Volken­ing LK, But­ler DA, An­der­son BJ, Laf­fel LM. Fam­i­ly-‍based psychoed­u­ca­tion and Care Am­bas­sador in­ter­ven­tion to im­prove glycemic con­trol in youth with type 1 di­a­betes: a ran­dom­ized trial. Pe­di­atr Di­a­betes 2014;15:142–150
37. Laf­fel LMB, Vangsness L, Con­nell A, Goebel-‍ Fab­bri A, But­ler D, An­der­son BJ. Im­pact of am­bu­la­to­ry, fam­i­ly-focused team­work in­ter­ven­tion on glycemic con­trol in youth with type 1 di­a­betes. J Pe­di­atr 2003;142:409–416
38. An­der­son BJ, Vangsness L, Con­nell A, But­ler D, Goebel-‍Fab­bri A, Laf­fel LMB. Fam­i­ly conflict, ad­her­ence, and gly­caemic con­trol in youth with short du­ra­tion type 1 di­a­betes. Di­a­bet Med 2002; 19:635–642
39. Helge­son VS, Pal­ladi­no DK. Im­pli­ca­tions of psy­choso­cial fac­tors for di­a­betes out­comes among chil­dren with type 1 di­a­betes: a re­view. Soc Per­son­al Psy­chol Com­pass 2012;6:228–242
40. Mc­Carthy AM, Lind­gren S, Men­geling MA, Tsa­likian E, En­g­vall J. Fac­tors as­so­ci­at­ed with aca­dem­ic achieve­ment in chil­dren with type 1 di­a­betes. Di­a­betes Care 2003;26:112–117
41. Kuther TL. Med­i­cal de­ci­sion-‍mak­ing and mi­nors: is­sues of con­sent and as­sent. Ado­lescence 2003;38:343–358
42. Cole­man DL, Rosoff PM. The legal au­thor­i­ty of ma­ture mi­nors to con­sent to gen­er­al med­i­cal treat­ment. Pe­di­atrics 2013;131:786–793
43. Charron-‍Prochownik D, Serei­ka SM, Beck­er D, et al. Long-‍term ef­fects of the booster-en­hanced READY-‍Girls pre­con­cep­tion coun­sel­ing pro­gram on in­ten­tions and be­hav­iors for fam­i­ly plan­ning in teens with di­a­betes. Di­a­betes Care 2013;36:3870–3874
44. Charron-‍Prochownik D, Downs J. Di­a­betes and Re­pro­duc­tive Health for Girls. Alexan­dria, VA, Amer­i­can Di­a­betes As­so­ci­a­tion, 2016
45. Markowitz JT, But­ler DA, Volken­ing LK, An­ti­s­del JE, An­der­son BJ, Laf­fel LMB. Brief screen­ing tool for dis­or­dered eat­ing in di­a­betes: in­ter­nal con­sistency and ex­ter­nal va­lid­i­ty in a con­tem­po­rary sam­ple of pe­di­atric pa­tients with type 1 di­a­betes. Di­a­betes Care 2010;33:495–500
46. Goebel-‍Fab­bri AE. Dis­turbed eat­ing be­hav­iors and eat­ing dis­or­ders in type 1 di­a­betes: clin­i­cal significance and treat­ment rec­om­men­da­tions. Curr Diab Rep 2009;9:133–139
47. Atik Altınok Y, O¨ zgu¨r S, Meseri R, O¨ zen S, Dar­can S¸, Go¨ks¸en D. Reliabil­i­ty and va­lid­i­ty of the di­a­beteseat­ing prob­lemsurvey in Turk­ish chil­dren and ado­les­cents with type 1 di­a­betes mel­li­tus. J Clin Res Pe­di­atr En­docrinol 2017;9:323–328
48. Saßmann H, Al­brecht C, Busse-‍Widmann P, et al. Psy­cho­me­t­ric prop­er­ties of the Ger­man ver­sion of the Di­a­betes Eat­ing Prob­lem Sur­vey-‍ Re­vised: ad­di­tional benefit of dis­ease-‍specific screen­ing in ado­les­cents with type 1 di­a­betes. Di­a­bet Med 2015;32:1641–1647
49. Lawrence JM, Yi-‍Fra­zier JP, Black MH, et al.; SEARCH for Di­a­betes in Youth Study Group. De­mo­graph­ic and clin­i­cal cor­re­lates of di­a­betes-‍re­lat­ed qual­i­ty of life among youth with type 1 di­a­betes. J Pe­di­atr 2012;161:201–207.e2
50. Wist­ing L, Frøis­land DH, Skri­varhaug T, Dahl- Jørgensen K, Rø O. Dis­turbed eat­ing be­hav­ior and omis­sion of in­sulin in ado­les­cents re­ceiv­ing in­ten­sified in­sulin treat­ment: a na­tion­wide pop­u­la­tion-‍based study. Di­a­betes Care 2013;36: 3382–3387
51. Maahs DM, Her­mann JM, Du­Bose SN, et al.; DPV Ini­tia­tive; T1D Ex­change Clin­ic Net­work. Con­trast­ing the clin­i­cal care and out­comes of 2,622 chil­dren with type 1 di­a­betes less than 6 years of age in the Unit­ed States T1D Ex­change and Ger­man/Aus­trian DPV reg­istries. Di­a­betologia 2014;57:1578–1585
52. Haynes A, Her­mann JM, Miller KM, et al.; T1D Ex­change, WACDD and DPV reg­istries. Se­vere hy­po­glycemia rates are not as­so­ci­at­ed with HbA1c: a cross-sec­tional anal­y­sis of 3 con­tem­po­rary pe­di­atric di­a­betes reg­istry databas­es. Pe­di­atr Di­a­betes 2017;18:643–650
53. Ryan CM. Why is cog­ni­tive dysfunc­tion as­so­ci­at­ed with the de­vel­op­ment of di­a­betes early in life? The diathe­sis hy­poth­e­sis. Pe­di­atr Di­a­betes 2006;7:289–297
54. Cameron FJ. The im­pact of di­a­betes on brain func­tion in child­hood and ado­les­cence. Pe­di­atr Clin North Am 2015;62:911–927
55. Camp­bell MS, Schatz DA, Chen V, et al.; T1D Ex­change Clin­ic Net­work. A con­trast be­tween chil­dren and ado­les­cents with ex­cel­lent and poor con­trol: the T1D Ex­change clin­ic reg­istry ex­pe­ri­ence. Pe­di­atr Di­a­betes 2014;15:110–117
56. Coop­er MN, O’Con­nell SM, Davis EA, Jones TW. A pop­u­la­tion-‍based study of risk fac­tors for se­vere hy­po­gly­caemia in a con­tem­po­rary co­hort of child­hood-‍onset type 1 di­a­betes. Di­a­betologia 2013;56:2164–2170
57. Bergen­stal RM, Klonoff DC, Garg SK, et al.; AS­PIRE In-‍Home Study Group. Thresh­old-‍based in­sulin-‍pump in­ter­rup­tion for re­duc­tion of hy­po­glycemia. N Engl J Med 2013;369:224–232
58. Abra­ham MB, Davey R, O’Grady MJ, et al. Ef­fec­tive­ness of a pre­dic­tive al­go­rithm in the pre­ven­tion of ex­er­cise-induced hy­po­glycemia in type 1 di­a­betes. Di­a­betes Tech­nol Ther 2016;18: 543–550
59. Buck­ing­ham BA, Bai­ley TS, Chris­tiansen M, et al. Eval­u­a­tion of a pre­dic­tive low-‍glu­cose man­age­ment sys­tem in-‍clin­ic. Di­a­betes Tech­nol Ther 2017;19:288–292
60. Nimri R, Muller I, Atlas E, et al. MD-‍Logic overnight con­trol for 6 weeks of home use in pa­tients with type 1 di­a­betes: ran­dom­ized crossover trial. Di­a­betes Care 2014;37:3025–3032
61. Thabit H, Tauschmann M, Allen JM, et al. Home use of an artificial beta cell in type 1 di­a­betes. N Engl J Med 2015;373:2129–2140
62. Bergen­stal RM, Garg S, Weinz­imer SA, et al. Safe­ty of a hy­brid closed-‍loop in­sulin de­liv­ery sys­tem in pa­tients with type 1 di­a­betes. JAMA 2016;316:1407–1408
63. Ko­vatchev B, Cheng P, An­der­son SM, et al. Fea­si­bil­i­ty of long-‍term closed-‍loop con­trol: a mul­ti­cen­ter 6-‍month trial of 24/7 au­to­mat­ed in­sulin de­liv­ery. Di­a­betes Tech­nol Ther 2017;19:18–24
64. El-‍Khatib FH, Bal­liro C, Hillard MA, et al. Home useof a bi­hor­mon­al­bion­ic pan­creas ver­sus in­sulin pump ther­a­py in adults with type 1 di­a­betes: a mul­ti­cen­tre ran­domised crossover trial. Lancet 2017;389:369–380
65. Levine BS, An­der­son BJ, But­ler DA, An­ti­s­del JE, Brack­ett J, Laf­fel LM. Pre­dic­tors of glycemic con­trol and short-‍term ad­verse out­comes in youth with type 1 di­a­betes. J Pe­di­atr 2001; 139:197–203
66. Miller KM, Beck RW, Bergen­stal RM, et al.; T1D Ex­change Clin­ic Net­work. Ev­i­dence of a strong as­so­ci­a­tion be­tween fre­quen­cy of self-‍mon­i­tor­ing of blood glu­cose and hemoglobin A1c lev­els in T1D Ex­change clin­ic reg­istry par­tic­i­pants. Di­a­betes Care 2013;36:2009–2014
67. Rosen­bauer J, Dost A, Karges B, et al.; DPV Ini­tia­tive and the Ger­man BMBF Com­pe­tence Net­work Di­a­betes Mel­li­tus. Im­proved metabol­ic con­trol in chil­dren and ado­les­cents with type 1 di­a­betes: a trend anal­y­sis using prospec­tive mul­ti­cen­ter data from Ger­many and Aus­tria. Di­a­betes Care 2012;35:80–86
68. Cameron FJ, de Beau­fort C, Aanstoot HJ, et al.; Hvi­do­ere Interna­tion­al Study Group. Lessons from the Hvi­do­ere Interna­tion­al Study Group on child­hood di­a­betes: be dog­mat­ic about out­come and flex­i­ble in ap­proach. Pe­di­atr Di­a­betes 2013;14:473–480
69. Nimri R, Wein­trob N, Ben­za­quen H, Ofan R, Fay­man G, Phillip M. In­sulin pump ther­a­py in youth with type 1 di­a­betes: a ret­ro­spec­tive paired study. Pe­di­atrics 2006;117:2126–2131
70. Doyle EA, Weinz­imer SA, Stef­fen AT, Ahern JAH, Vin­cent M, Tam­bor­lane WVA. A ran­dom­ized, prospec­tive trial com­par­ing the efficacy of con­tin­u­ous sub­cu­ta­neous in­sulin in­fu­sion with mul­ti­ple daily in­jec­tions using in­sulin glargine. Di­a­betes Care 2004;27:1554–1558
71. Swift PGF, Skin­ner TC, de Beau­fort CE, et al.; Hvi­do­ere Study Group on Child­hood Di­a­betes. Tar­get set­ting in in­ten­sive in­sulin man­age­ment is as­so­ci­at­ed with metabol­ic con­trol: the Hvi­do­ere child­hood di­a­betes study group cen­tre dif­fer­ences study 2005. Pe­di­atr Di­a­betes 2010;11: 271–278
72. Hugh­es JW, Rid­dlesworth TD, DiMeglio LA, Miller KM, Rick­els MR, McGill JB. Au­toim­mune dis­eases in chil­dren and adults with type 1 di­a­betes from the T1D Ex­change Clin­ic Reg­istry. J Clin En­docrinol Metab 2016;101:4931–4937
73. Ka­haly GJ, Hansen MP. Type 1 di­a­betes as­so­ci­at­ed au­toim­mu­ni­ty. Au­toim­mun Rev 2016; 15:644–648
74. Rold´an MB, Alon­so M, Bar­rio R. Thy­roid au­toim­mu­ni­ty in chil­dren and ado­les­cents with type 1 di­a­betes mel­li­tus. Di­a­betes Nutr Metab 1999;12:27–31
75. Tri­o­lo TM, Arm­strong TK, Mc­Fann K, et al. Ad­di­tion­al au­toim­mune dis­ease found in 33% of pa­tients at type 1 di­a­betes onset. Di­a­betes Care 2011;34:1211–1213
76. Ko­r­donouri O, Deiss D, Danne T, Dorow A, Bassir C, Gr¨uters-‍Kieslich A. Pre­dic­tiv­i­ty of thy­roid au­toan­ti­bod­ies for the de­vel­op­ment of thy­roid dis­or­ders in chil­dren and ado­les­cents with type 1 di­a­betes. Di­a­bet Med 2002;19:518–521
77. Dost A, Rohrer TR, Fro¨hlich-‍Reiterer E, et al.; DPV Ini­tia­tive and the Ger­man Com­pe­tence Net­work Di­a­betes Mel­li­tus. Hyperthy­roidism in 276 chil­dren and ado­les­cents with type 1 di­a­betes from Ger­many and Aus­tria. Horm Res Pae­di­a­tr 2015;84:190–198
78. Jons­dot­tir B, Lars­son C, Carls­son A, et al.; Bet­ter Di­a­betes Di­ag­no­sis Study Group. Thy­roid and islet au­toan­ti­bod­ies pre­dict au­toim­mune thy­roid dis­ease at type 1 di­a­betes di­ag­no­sis. J Clin En­docrinol Metab 2017;102:1277–1285
79. Mohn A, Di Michele S, Di Luzio R, Tu­mi­ni S, Chiarel­li F. The ef­fect of subclin­i­cal hypothy­roidism on metabol­ic con­trol in chil­dren and ado­les­cents with type 1 di­a­betes mel­li­tus. Di­a­bet Med 2002;19:70–73
80. Holmes GKT. Screen­ing for coeli­ac dis­ease in type 1 di­a­betes. Arch Dis Child 2002;87:495– 498
81. Rew­ers M, Liu E, Sim­mons J, Re­don­do MJ, Hof­fen­berg EJ. Celi­ac dis­ease as­so­ci­at­ed with type 1 di­a­betes mel­li­tus. En­docrinol Metab Clin North Am 2004;33:197–214
82. Pham-‍Short A, Don­aghue KC, Am­bler G, Phe­lan H, Twigg S, Craig ME. Screen­ing for celi­ac dis­ease in type 1 di­a­betes: a sys­tematic re­view. Pe­di­atrics 2015;136:e170–e176
83. Craig ME, Prinz N, Boyle CT, et al.; Aus­tralasian Di­a­betes Data Net­work (ADDN); T1D Ex­change Clin­ic Net­work (T1DX); Na­tion­al Pae­di­a­tric Di­a­betes Audit (NPDA) and the Royal Col­lege of Pae­di­a­trics and Child Health; Prospec­tive Di­a­betes Fol­low-‍up Reg­istry (DPV) ini­tia­tive. Preva­lence of celi­ac dis­ease in 52,721 youth with type 1 di­a­betes: interna­tion­al com­par­i­son across three con­ti­nents. Di­a­betes Care 2017;40:1034–1040
84. Sim­mons JH, Fos­ter NC, Rid­dlesworth TD, et al.; T1D Ex­change Clin­ic Net­work. Sex- and age-‍de­pen­dent ef­fects of celi­ac dis­ease on growth and weight gain in chil­dren with type 1 di­a­betes: anal­y­sis of the Type 1 Di­a­betes Ex­change Clin­ic Reg­istry. Pe­di­atr Di­a­betes 2018;19:741–748
85. Rubio-‍Tapia A, Hill ID, Kelly CP, Calder­wood AH, Mur­ray JA; Amer­i­can Col­lege of Gas­troen­terol­o­gy. ACG clin­i­cal guide­lines: di­ag­no­sis and man­age­ment of celi­ac dis­ease. Am J Gas­troen­terol 2013;108:656–676
86. Paul SP, Sand­hu BK, Spray CH, Ba­sude D, Ra­mani P. Ev­i­dence sup­porting serol­o­gy-‍based path­way for di­ag­nos­ing celi­ac dis­ease in asymp­tomat­ic chil­dren from high-‍risk groups. J Pe­di­atr Gas­troen­terol Nutr 2018;66:641–644
87. Abid N, Mc­Glone O, Card­well C, Mc­Cal­lion W, Car­son D. Clin­ical and metabol­ic ef­fects of gluten free diet in chil­dren with type 1 di­a­betes and coeli­ac dis­ease. Pe­di­atr Di­a­betes 2011;12:322–325
88. Husby S, Ko­let­zko S, Korponay-‍Szab´o IR, et al.; ESPGHAN Work­ing Group on Coeli­ac Dis­ease Di­ag­no­sis; ESPGHAN Gas­troen­terol­o­gy Com­mit­tee; Eu­ro­pean So­ci­ety for Pe­di­atric Gas­troen­terol­o­gy, Hep­a­tol­o­gy, and Nu­tri­tion. Eu­ro­pean So­ci­ety for Pe­di­atric Gas­troen­terol­o­gy, Hep­a­tol­o­gy, and Nu­tri­tion guide­lines for the di­ag­no­sis of coeli­ac dis­ease. J Pe­di­atr Gas­troen­terol Nutr 2012;54:136–160
89. Kurp­pa K, Paavola A, Collin P, et al. Ben­e­fits of a gluten-‍free diet for asymp­tomat­ic pa­tients with sero­log­ic mark­ers of celi­ac dis­ease. Gas­troen­terol­o­gy 2014;147:610–617.e1
90. Mar­cov­ec­chio ML, Chiesa ST, Bond S, et al.; AdDIT Study Group. ACE in­hibitors and statins in ado­les­cents with type 1 di­a­betes. N Engl J Med 2017;377:1733–1745
91. de Fer­ran­ti SD, de Boer IH, Fon­se­ca V, et al. Type 1 di­a­betes mel­li­tus and car­dio­vas­cu­lar dis­ease: a sci­en­tific state­mentfrom the Amer­i­can Heart As­so­ci­a­tion and Amer­i­can Di­a­betes As­so­ci­a­tion. Cir­cu­la­tion 2014;130:1110–1130
92. Ro­driguez BL, Fu­ji­mo­to WY, Mayer-‍Davis EJ, et al. Preva­lence of car­dio­vas­cu­lar dis­ease risk fac­tors in U.S. chil­dren and ado­les­cents with di­a­betes: the SEARCH for Di­a­betes in Youth study. Di­a­betes Care 2006;29:1891–1896
93. Margeirs­dot­tir HD, Larsen JR, Brun­borg C, Over­by NC, Dahl-‍Jørgensen K; Nor­we­gian Study Group for Child­hood Di­a­betes. High preva­lence of car­dio­vas­cu­lar risk fac­tors in chil­dren and ado­les­cents with type 1 di­a­betes: a pop­u­la­tion-‍based study. Di­a­betologia 2008; 51:554–561
94. Schwab KO, Do­er­fer J, Heck­er W, et al.; DPV Ini­tia­tive of the Ger­man Work­ing Group for Pe­di­atric Di­a­betology. Spec­trum and preva­lence of athero­genic risk fac­tors in 27,358 chil­dren, ado­les­cents, and young adults with type 1 di­a­betes: cross-sec­tional data from the Ger­man di­a­betes doc­u­men­ta­tion and qual­i­ty man­age­ment sys­tem (DPV). Di­a­betes Care 2006;29:218– 225
95. Singh TP, Groehn H, Kazmers A. Vas­cu­lar func­tion and carotid in­ti­mal-medial thick­ness in chil­dren with in­sulin-dependent di­a­betes mel­li­tus. J Am Coll Car­di­ol 2003;41:661–665
96. Haller MJ, Stein J, Shus­ter J, et al. Pe­riph­er­al artery tonom­e­try demon­strates al­tered en­dothe­lial func­tion in chil­dren with type 1 di­a­betes. Pe­di­atr Di­a­betes 2007;8:193–198
97. Urbina EM, Wadwa RP, Davis C, et al. Preva­lence of in­creased ar­te­ri­al stiff­ness in chil­dren with type 1 di­a­betes mel­li­tus dif­fers by mea­sure­ment site and sex: the SEARCH for Di­a­betes in Youth Study. J Pe­di­atr 2010;156:731–737.e1
98. Ex­pert Panel on In­te­grat­ed Guide­lines for Car­dio­vas­cu­lar Health and Risk Re­duc­tion in Chil­dren and Ado­les­cents; Na­tion­al Heart, Lung, and Blood In­sti­tute. Ex­pert Panel on In­te­grat­ed Guide­lines for Car­dio­vas­cu­lar Health and Risk Re­duc­tion in Chil­dren and Ado­les­cents: sum­ma­ry re­port. Pe­di­atrics 2011;128(Suppl. 5): S213–S256
99. Daniels SR, Greer FR; Com­mit­tee on Nu­tri­tion. Lipid screen­ing and car­dio­vas­cu­lar health in child­hood. Pe­di­atrics 2008;122:198–208
100. Kavey R-EW, Al­la­da V, Daniels SR, et al.; Amer­i­can Heart As­so­ci­a­tion Ex­pert Panel on Pop­u­la­tion and Pre­ven­tion Sci­ence; Amer­i­can Heart As­so­ci­a­tion Coun­cil on Car­dio­vas­cu­lar Dis­ease in the Young; Amer­i­can Heart As­so­ci­a­tion Coun­cil on Epi­demi­ol­o­gy and Pre­ven­tion; Amer­i­can Heart As­so­ci­a­tion Coun­cil on Nu­tri­tion, Phys­i­cal Ac­tiv­i­ty and Metabolism; Amer­i­can Heart As­so­ci­a­tion Coun­cil on High Blood Pres­sure Re­search; Amer­i­can Heart As­so­ci­a­tion Coun­cil on Car­dio­vas­cu­lar Nurs­ing; Amer­i­can Heart As­so­ci­a­tion Coun­cil on the Kid­ney in Heart Dis­ease; In­ter­dis­ci­plinary Work­ing Group on Qual­i­ty of Care and Out­comes Re­search. Car­dio­vas­cu­lar risk re­duc­tion in high-‍risk pe­di­atric pa­tients: a sci­en­tific state­ment from the Amer­i­can Heart As­so­ci­a­tion Ex­pert Panel on Pop­u­la­tion and Pre­ven­tion Sci­ence; the Coun­cils on Car­dio­vas­cu­lar Dis­ease in the Young, Epi­demi­ol­o­gy and Pre­ven­tion, Nu­tri­tion, Phys­i­cal Ac­tiv­i­ty S162 Chil­dren and Ado­les­cents Di­a­betes Care Vol­ume 42, Sup­ple­ment 1, Jan­uary 2019 and Metabolism, High Blood Pres­sure Re­search, Car­dio­vas­cu­lar Nurs­ing, and the Kid­ney in Heart Dis­ease; and the In­ter­dis­ci­plinary Work­ing Group on Qual­i­ty of Care and Out­comes Re­search: en­dorsed by the Amer­i­can Acade­my of Pe­di­atrics. Cir­cu­la­tion 2006;114:2710–2738
101. Cadario F, Pro­dam F, Pasqual­ic­chio S, et al. Lipid profile and nu­tri­tional in­take in chil­dren and ado­les­cents with type 1 di­a­betes im­prove after a struc­tured di­eti­cian train­ing to a Mediter­ranean-‍style diet. J En­docrinol In­vest 2012;35:160–168
102. Salem MA, AboE­lAs­rar MA, El­bar­bary NS, El­Hi­laly RA, Re­faat YM. Is ex­er­cise a ther­a­peu­tic tool for im­provement of car­dio­vas­cu­lar risk fac­tors in ado­les­cents with type 1 di­a­betes mel­li­tus? A ran­domised con­trolled trial. Di­a­betol Metab Syndr 2010;2:47
103. Mc­Crindle BW, Urbina EM, Den­ni­son BA, et al.; Amer­i­can Heart As­so­ci­a­tion Atheroscle­ro­sis, Hy­per­ten­sion, and Obe­si­ty in Youth Com­mit­tee; Amer­i­can Heart As­so­ci­a­tion Coun­cil of Car­dio­vas­cu­lar Dis­ease in the Young; Amer­i­can Heart As­so­ci­a­tion Coun­cil on Car­dio­vas­cu­lar Nurs­ing. Drug ther­a­py of high-‍risk lipid abnor­malities in chil­dren and ado­les­cents: a sci­en­tific state­ment from the Amer­i­can Heart As­so­ci­a­tion Atheroscle­ro­sis, Hy­per­ten­sion, and Obe­si­ty in Youth Com­mit­tee, Coun­cil of Car­dio­vas­cu­lar Dis­ease in the Young, with the Coun­cil on Car­dio­vas­cu­lar Nurs­ing. Cir­cu­la­tion 2007;115: 1948–1967
104. Salo P, Vi­ikari J, Ha¨ma¨la¨inen M, et al. Serum choles­terol ester fatty acids in 7- and 13-‍month-old chil­dren in a prospec­tive ran­dom­ized trial of a low-‍sat­u­rat­ed fat, low-‍choles­terol diet: the STRIP baby pro­ject: Spe­cial Turku coro­nary Risk fac­tor In­ter­ven­tion Pro­ject for chil­dren. Acta Pae­di­a­tr 1999;88:505–512
105. Maahs DM, Dabe­lea D, D’Agosti­no RB Jr, et al.; SEARCH for Di­a­betes in Youth Study. Glu­cose con­trol pre­dicts 2-year change in lipid profile in youth with type 1 di­a­betes. J Pe­di­atr 2013;162:101–107.e1
106. Mc­Crindle BW, Ose L, Marais AD. Efficacy and safe­ty of ator­vas­tatin in chil­dren and ado­les­cents with fa­mil­ial hypercholes­terolemia or se­vere hy­per­lipi­demia: a mul­ti­cen­ter, ran­dom­ized, placebo-con­trolled trial. J Pe­di­atr 2003;143:74–80
107. Wieg­man A, Hut­ten BA, de Groot E, et al. Efficacy and safe­ty of statin ther­a­py in chil­dren with fa­mil­ial hypercholes­terolemia: a ran­dom­ized con­trolled trial. JAMA 2004;292:331–337
108. Karter AJ, Stevens MR, Gregg EW, et al. Ed­u­ca­tional dis­par­i­ties in rates of smok­ing among di­a­bet­ic adults: the Trans­lat­ing Re­search Into Ac­tion for Di­a­betes study. Am J Pub­lic Health 2008;98:365–370
109. Reynolds K, Liese AD, An­der­son AM, et al. Preva­lence of to­bac­co use and as­so­ci­a­tion be­tween cardiometabol­ic risk fac­tors and cigarette smok­ing in youth with type 1 or type 2 di­a­betes mel­li­tus. J Pe­di­atr 2011;158:594–601.e1
110. Scott LJ, War­ram JH, Hanna LS, Laf­fel LM, Ryan L, Krolews­ki AS. A nonlin­ear ef­fect of hy­per­glycemia and cur­rent cigarette smok­ing are major de­ter­mi­nants of the onset of microal­bu­minuria in type 1 di­a­betes. Di­a­betes 2001; 50:2842–2849
111. Chaf­fee BW, Watkins SL, Glantz SA. Elec­tron­ic cigarette use and pro­gres­sion from ex­per­i­men­ta­tion to es­tab­lished smok­ing. Pe­di­atrics 2018;141:e20173594
112. Audrain-‍Mc­Gov­ern J, Stone MD, Bar­ring­ton-‍Trimis J, Unger JB, Lev­en­thal AM. Ado­les­cent e-‍cigarette, hookah, and con­ven­tion­al cigarette use and sub­se­quent mar­i­jua­na use. Pe­di­atrics 2018;142:e20173616
113. Daniels M, Du­Bose SN, Maahs DM, et al.; T1D Ex­change Clin­ic Net­work. Fac­tors as­so­ci­at­ed with microal­bu­minuria in 7,549 chil­dren and ado­les­cents with type 1 di­a­betes in the T1D Ex­change clin­ic reg­istry. Di­a­betes Care 2013;36: 2639–2645
114. Schwartz GJ, Work DF. Mea­surement and es­ti­ma­tion of GFR in chil­dren and ado­les­cents. Clin J Am Soc Nephrol 2009;4:1832–1843
115. Inker LA, Schmid CH, Tighiouart H, et al.; CKD-‍EPI In­vestigators. Es­ti­mat­ing glomeru­lar filtra­tion rate from serum cre­a­ti­nine and cys­tatin C. N Engl J Med 2012;367:20–29
116. Cho YH, Craig ME, Hing S, et al. Mi­crovas­cu­lar com­pli­ca­tions as­sessment in ado­les­cents with 2- to 5-yr du­ra­tion of type 1 di­a­betes from 1990 to 2006. Pe­di­atr Di­a­betes 2011;12:682– 689
117. Jaisw­al M, Divers J, Dabe­lea D, et al. Preva­lence of and risk fac­tors for di­a­bet­ic pe­riph­er­al neu­ropa­thy in youth with type 1 and type 2 di­a­betes: SEARCH for Di­a­betes in Youth Study. Di­a­betes Care 2017;40:1226–1232
118. Pop-‍Busui R, Boul­ton AJM, Feld­man EL, et al. Di­a­bet­ic neu­ropa­thy: a po­si­tion state­ment by the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2017;40:136–154
119. Lawrence JM, Im­per­a­tore G, Pet­titt DJ, et al. In­ci­dence of di­a­betes in Unit­ed States youth by di­a­betes type, race/eth­nicity, and age, 2008– 2009 (Ab­stract). Di­a­betes 2014;63(Suppl. 1): A407
120. Im­per­a­tore G, Boyle JP, Thomp­son TJ, et al.; SEARCH for Di­a­betes in Youth Study Group. Pro­jections of type 1 and type 2 di­a­betes bur­den in the U.S. pop­u­la­tion aged <20 years through 2050: dy­nam­ic mod­el­ing of in­ci­dence, mor­tal­i­ty, and pop­u­la­tion growth. Di­a­betes Care 2012;35: 2515–2520
121. Pet­titt DJ, Tal­ton J, Dabe­lea D, et al.; SEARCH for Di­a­betes in Youth Study Group. Preva­lence of di­a­betes in U.S. youth in 2009: the SEARCH­for Di­a­betesin Youth Study. Di­a­betes Care 2014;37:402–408
122. Copeland KC, Zeitler P, Geffn­er M, et al.; TODAY Study Group. Char­ac­ter­is­tics of ado­les­cents and youth with re­cent-‍onset type 2 di­a­betes: the TODAY co­hort at base­line. J Clin En­docrinol Metab 2011;96:159–167
123. Ar­sla­ni­an SA. Metabol­ic dif­fer­ences be­tween Cau­casian and African-‍Amer­i­can chil­dren and the re­la­tionship to type 2 di­a­betes mel­li­tus. J Pe­di­atr En­docrinol Metab 2002;15(Suppl. 1): 509–517
124. Naughton MJ, Rug­giero AM, Lawrence JM, et al.; SEARCH for Di­a­betes in Youth Study Group. Health-‍re­lat­ed qual­i­ty of life of chil­dren and ado­les­cents with type 1 or type 2 di­a­betes mel­li­tus: SEARCH for Di­a­betes in Youth Study. Arch Pe­di­atr Ado­lesc Med 2008;162:649–657
125. Wad­den TA, Webb VL, Moran CH, Bail­er BA. Lifestyle modification for obe­si­ty: new de­vel­op­ments in diet, phys­i­cal ac­tiv­i­ty, and be­hav­ior ther­a­py. Cir­cu­la­tion 2012;125:1157–1170
126. Whalen DJ, Belden AC, Till­man R, Barch DM, Luby JL. Early ad­ver­si­ty, psy­chopathol­o­gy, and la­tent class profiles of glob­al phys­i­cal health from preschool through early ado­les­cence. Psy­cho­som Med 2016;78:1008–1018
127. Dabe­lea D, Mayer-‍Davis EJ, Say­dah S, et al.; SEARCH for Di­a­betes in Youth Study. Preva­lence of type 1 and type 2 di­a­betes among chil­dren and ado­les­cents from 2001 to 2009. JAMA 2014;311: 1778–1786
128. Buse JB, Kauf­man FR, Lin­der B, Hirst K, El Ghorm­li L, Willi S; HEALTHY Study Group. Di­a­betes screen­ing with hemoglobin A1c ver­sus fast­ing plas­ma glu­cose in a multieth­nic middl-‍school co­hort. Di­a­betes Care 2013;36:429–435
129. Klin­gen­smith GJ, Pyle L, Ar­sla­ni­an S, et al.; TODAY Study Group. The pres­ence of GAD and IA-2 an­ti­bod­ies in youth with a type 2 di­a­betes phe­no­type: re­sults from the TODAY study. Di­a­betes Care 2010;33:1970–1975
130. Han­non TS, Ar­sla­ni­an SA. The chang­ing face ofdi­a­betesinyouth: lessonslearnedfromstud­ies of type 2 di­a­betes. Ann N Y Acad Sci 2015;1353: 113–137
131. Ka­pa­dia C, Zeitler P; Drugs and Ther­a­peu­tics Com­mit­tee of the Pe­di­atric En­docrine So­ci­ety. Hemoglobin A1c mea­sure­ment for the di­ag­no­sis of type 2 di­a­betes in chil­dren. Int J Pe­di­atr En­docrinol 2012;2012:31
132. Kester LM, Hey H, Han­non TS. Using hemoglobin A1c for predi­a­betes and di­a­betes di­ag­no­sis in ado­les­cents: can adult rec­om­men­da­tions be up­held for pe­di­atric use? J Ado­lesc Health 2012;50:321–323
133. Wu E-L, Kazzi NG, Lee JM. Cost-ef­fec­tiveness of screen­ing strate­gies for iden­ti­fy­ing pe­di­atric di­a­betes mel­li­tus and dys­g­lycemia. JAMA Pe­di­atr 2013;167:32–39
134. Dabe­lea D, Rew­ers A, Staf­ford JM, et al.; SEARCH for Di­a­betes in Youth Study Group. Trends in the preva­lence of ke­toaci­do­sis at di­a­betes di­ag­no­sis: the SEARCH for Di­a­betes in Youth Study. Pe­di­atrics 2014;133:e938–e945
135. Hutchins J, Bara­jas RA, Hale D, Es­caname E, Lynch J. Type 2 di­a­betes in a 5-‍year-‍old and sin­gle cen­ter ex­pe­ri­ence of type 2 di­a­betes in youth under 10. Pe­di­atr Di­a­betes 2017;18:674–677
136. Fer­rara CT, Geyer SM, Liu Y-F, et al.; Type 1 Di­a­betes Tri­al­Net Study Group. Ex­cess BMI in child­hood: a modifiable risk fac­tor for type 1 di­a­betes de­vel­op­ment? Di­a­betes Care 2017;40: 698–701
137. Re­don­do MJ, Geyer S, Steck AK, et al.; Type 1 Di­a­betes Tri­al­Net Study Group. TCF7L2 ge­net­ic vari­ants con­tribute to phe­no­typ­ic het­ero­gene­ity of type 1 di­a­betes. Di­a­betes Care 2018;41:311– 317
138. Pinhas-‍Hamiel O, Dolan LM, Zeitler PS. Di­a­bet­ic ke­toaci­do­sis among obese African-‍ Amer­i­can ado­les­cents with NIDDM. Di­a­betes Care 1997;20:484–486
139. TODAY Study Group. Safe­ty and tolerabil­i­ty of the treat­ment of youth-‍onset type 2 di­a­betes: the TODAY ex­pe­ri­ence. Di­a­betes Care 2013;36: 1765–1771
140. TODAY Study Group. Retinopa­thy in youth with type 2 di­a­betes par­tic­i­pat­ing in the TODAY clin­i­cal trial. Di­a­betes Care 2013;36:1772–1774
141. TODAY Study Group. Lipid and inflam­ma­to­ry car­dio­vas­cu­lar risk wors­ens over 3 years in youth with type 2 di­a­betes: the TODAY clin­i­cal trial. Di­a­betes Care 2013;36:1758–1764
142. TODAY Study Group. Rapid rise in hy­per­ten­sion and nephropa­thy in youth with type 2 di­a­betes: the TODAY clin­i­cal trial. Di­a­betes Care 2013;36:1735–1741
143. Grey M, Schrein­er B, Pyle L. De­vel­op­ment of a di­a­betes ed­u­ca­tion pro­gram for youth with type 2 di­a­betes. Di­a­betes Educ 2009;35:108–116
144. Amer­i­can Di­a­betes As­so­ci­a­tion. Be Healthy Today; Be Healthy For Life [In­ter­net]. Avail­able from http:/‍/‍main.di­a­betes.org/dorg/PDFs/Type-‍ 2-Di­a­betes-‍in-Youth/Type-2-Di­a­betes-‍in-Youth.pdf. Ac­cessed 16 Oc­to­ber 2018
145. Atkin­son A, Rad­jen­ovic D. Meet­ing qual­i­ty stan­dards for self-‍man­age­ment ed­u­ca­tion in pe­di­atric type 2 di­a­betes. Di­a­betes Spec­tr 2007;20:40–46
146. Copeland KC, Sil­ver­stein J, Moore KR, et al. Man­age­ment of newly di­ag­nosed type 2 di­a­betes mel­li­tus (T2DM) in chil­dren and ado­les­cents. Pe­di­atrics 2013;131:364–382
147. Levitt Katz LE, Bacha F, Gid­ding SS, et al.; TODAY Study Group. Lipid profiles, inflam­ma­to­ry mark­ers, and in­sulin ther­a­py in youth with type 2 Di­a­betes. J Pe­di­atr 2018;196:208–216.e2
148. Zeitler P, Hirst K, Pyle L, et al.; TODAY Study Group. A clin­i­cal trial to main­tain glycemic con­trol in youth with type 2 di­a­betes. N Engl J Med 2012;366:2247–2256
149. Inge TH, Cour­coulas AP, Jenk­ins TM, et al.; Teen-‍LABS Con­sor­tium. Weight loss and health sta­tus 3 years after bariatric surgery in ado­les­cents. N Engl J Med 2016;374:113–123
150. Ru­bi­no F, Nathan DM, Eckel RH, et al.; Del­e­gates of the 2nd Di­a­betes Surgery Sum­mit. Metabol­ic surgery in the treat­ment al­go­rithm for type 2 di­a­betes: a joint state­ment by interna­tion­al di­a­betes or­ga­ni­za­tions. Di­a­betes Care 2016;39:861–877
151. Pratt JSA, Lenders CM, Dionne EA, et al. Best prac­tice up­dates for pe­di­atric/ado­les­cent weight loss surgery. Obe­si­ty (Sil­ver Spring) 2009; 17:901–910
152. Dolan K, Creighton L, Hop­kins G, Field­ing G. La­paro­scop­ic gas­tric band­ing in mor­bid­ly obese ado­les­cents. Obes Surg 2003;13:101– 104
153. Sug­er­man HJ, Sug­er­man EL, De­Maria EJ, et al. Bariatric surgery for se­verely obese ado­les­cents. J Gas­troin­test Surg 2003;7:102–108
154. Inge TH, Gar­cia V, Daniels S, et al. A mul­ti­dis­ci­plinary ap­proach to the ado­les­cent bariatric sur­gi­cal pa­tient. J Pe­di­atr Surg 2004; 39:442–447; dis­cus­sion 446–447
155. Law­son ML, Kirk S, Mitchell T, et al.; Pe­di­atric Bariatric Study Group. One-yearout­comes of Roux-‍en-‍Y gas­tric by­pass for mor­bid­ly obese ado­les­cents: a mul­ti­cen­ter study from the Pe­di­atric Bariatric Study Group. J Pe­di­atr Surg 2006;41:137–143
156. Inge TH, Zeller M, Har­mon C, et al. Teen- Lon­gi­tu­di­nal As­sessment of Bariatric Surgery: method­olog­i­cal fea­tures of the first prospec­tive mul­ti­cen­ter study of ado­les­cent bariatric surgery. J Pe­di­atr Surg 2007;42:1969–1971
157. Ells LJ, Mead E, Atkin­son G, et al. Surgery for the treat­ment of obe­si­ty in chil­dren and ado­les­cents. Cochrane Database Syst Rev 2015;6: CD011740
158. Michal­sky MP, Inge TH, Sim­mons M, et al.; Teen-‍LABS Con­sor­tium. Car­dio­vas­cu­lar risk fac­tors in se­verely obese ado­les­cents: the Teen Lon­gi­tu­di­nal As­sessment of Bariatric Surgery (Teen-‍LABS) study. JAMA Pe­di­atr 2015;169: 438–444
159. Zein­od­di­ni A, Hei­dari R, Talebpour M. La­paro­scop­ic gas­tric pli­ca­tion in mor­bid­ly obese ado­les­cents: aprospec­tivestudy. Surg Obes Relat Dis 2014;10:1135–1139
160. Go¨thberg G, Gronowitz E, Flod­mark C-E, et al. La­paro­scop­ic Roux-‍en-‍Y gas­tric by­pass in ado­les­cents with mor­bid obe­si­tydsur­gi­cal as­pects and clin­i­cal out­come. Semin Pe­di­atr Surg 2014;23:11–16
161. Inge TH, Pri­geon RL, Elder DA, et al. In­sulin sen­si­tiv­i­ty and β-cell func­tion im­prove after gas­tric by­pass in se­verely obese ado­les­cents. J Pe­di­atr 2015;167:1042–1048.e1
162. Styne DM, Ar­sla­ni­an SA, Con­nor EL, et al. Pe­di­atric obe­si­tydas­sessment, treat­ment, and pre­ven­tion: an En­docrine So­ci­ety clin­i­cal prac­tice guide­line. J Clin En­docrinol Metab 2017;102: 709–757
163. Ep­pens MC, Craig ME, Cusumano J, et al. Preva­lence of di­a­betes com­pli­ca­tions in ado­les­cents with type 2 com­pared with type 1 di­a­betes. Di­a­betes Care 2006;29:1300–1306
164. Song SH, Hardis­ty CA. Early onset type 2 di­a­betes mel­li­tus: a harbinger for com­pli­ca­tions in later yearsdclin­i­cal ob­ser­va­tion from a sec­ondary care co­hort. QJM 2009;102:799–806
165. Zeitler P, Fu J, Tan­don N, et al.; Interna­tion­al So­ci­ety for Pe­di­atric and Ado­les­cent Di­a­betes. ISPAD Clin­ical Prac­tice Con­sen­sus Guide­lines 2014. Type 2 di­a­betes in the child and ado­les­cent. Pe­di­atr Di­a­betes 2014;15(Suppl. 20):26–46
166. Song SH. Compli­ca­tion char­ac­ter­is­tics be­tween young-‍onset type 2 ver­sus type 1 di­a­betes in a UK pop­u­la­tion. BMJ Open Di­a­betes Res Care 2015;3:e000044
167. Ce­falu WT. “TODAY” reflects on the chang­ing “faces” of type 2 di­a­betes. Di­a­betes Care 2013;36:1732–1734
168. Lawrence JM, Stan­di­ford DA, Loots B, et al.; SEARCH for Di­a­betes in Youth Study. Preva­lence and cor­re­lates of de­pressed mood among youth with di­a­betes: the SEARCH for Di­a­betes in Youth study. Pe­di­atrics 2006;117:1348–1358
169. Levitt Katz LE, Swami S, Abra­ham M, et al. Neuropsy­chi­atric dis­or­ders at the pre­sentation of type 2 di­a­betes mel­li­tus in chil­dren. Pe­di­atr Di­a­betes 2005;6:84–89
170. Lewis-‍Ferna´ndez R, Rotheram-‍Borus MJ, Betts VT, et al. Re­think­ing fund­ing pri­or­i­ties in men­tal health re­search. Br J Psy­chi­a­try 2016;208: 507–509
171. Reinehr T. Type 2 di­a­betes mel­li­tus in chil­dren and ado­les­cents. World J Di­a­betes 2013;4:270–281
172. Pinhas-‍Hamiel O, Hamiel U, Levy-‍Shraga Y. Eat­ing dis­or­ders in ado­les­cents with type 1 di­a­betes: chal­lenges in di­ag­no­sis and treat­ment. World J Di­a­betes 2015;6:517–526
173. TODAY Study Group. Binge eat­ing, mood, and qual­i­ty of life in youth with type 2 di­a­betes: base­line data from the TODAY study. Di­a­betes Care 2011;34:858–860
174. Shel­ton RC. De­pres­sion, an­tide­pres­sants, and weight gain in chil­dren. Obe­si­ty (Sil­ver Spring) 2016;24:2450
175. Baeza I, Vigo L, de la Serna E, et al. The ef­fects of an­tipsy­chotics on weight gain, weight-‍re­lat­ed hor­mones and ho­mo­cys­teine in chil­dren and ado­les­cents: a 1-year fol­low-‍up study. Eur Child Ado­lesc Psy­chi­a­try 2017;26:35–46
176. Klin­gen­smith GJ, Pyle L, Nadeau KJ, et al. Preg­nan­cy out­comes in youth with type 2 di­a­betes: the TODAY study ex­pe­ri­ence. Di­a­betes Care 2016;39:122–129
177. Ar­nett JJ. Emerg­ing adult­hood: a the­o­ry of de­vel­op­ment from the late teens through the twen­ties. Am Psy­chol 2000;55:469–480
178. Weissberg-‍Benchell J, Wolpert H, An­der­son BJ. Tran­si­tioning from pe­di­atric to adult care: a new ap­proach to the post-‍ado­les­cent young per­son with type 1 di­a­betes. Di­a­betes Care 2007; 30:2441–2446
179. Pe­ters A, Laf­fel L; Amer­i­can Di­a­betes As­so­ci­a­tion Tran­si­tions Work­ing Group. Di­a­betes care for emerg­ing adults: rec­om­men­da­tions for tran­si­tion from pe­di­atric to adult di­a­betes care sys­tems: a po­si­tion state­ment of the Amer­i­can Di­a­betes As­so­ci­a­tion, with repre­sentation by the Amer­i­can Col­lege of Os­teo­path­ic Fam­i­ly Physi­cians, the Amer­i­can Acade­my of Pe­di­atrics, the Amer­i­can As­so­ci­a­tion of Clin­ical En­docrinologists, the Amer­i­can Os­teo­path­ic As­so­ci­a­tion, the Cen­ters for Dis­ease Con­trol and Pre­ven­tion, Chil­dren with Di­a­betes, The En­docrine So­ci­ety, the Interna­tion­al So­ci­ety for Pe­di­atric and Ado­les­cent Di­a­betes, Ju­ve­nile Di­a­betes Re­search Foun­da­tion Interna­tion­al, the Na­tion­al Di­a­betes Ed­u­ca­tion Pro­gram, and the Pe­di­atric En­docrine So­ci­ety (for­mer­ly Law­son Wilkins Pe­di­atric En­docrine So­ci­ety). Di­a­betes Care 2011;34:2477–2485
180. Bry­den KS, Pevel­er RC, Stein A, Neil A, Mayou RA, Dunger DB. Clin­ical and psy­cho­log­i­cal course of di­a­betes from ado­les­cence to young adult­hood: a lon­gi­tu­di­nal co­hort study. Di­a­betes Care 2001;24:1536–1540
181. Laing SP, Jones ME, Swerd­low AJ, Bur­den AC, Gatling W. Psychoso­cial and so­cioe­co­nom­ic risk fac­tors for pre­ma­ture death in young peo­ple with type 1 di­a­betes. Di­a­betes Care 2005;28: 1618–1623
182. Mays JA, Jack­son KL, Derby TA, et al. An eval­u­a­tion of recur­rent di­a­bet­ic ke­toaci­do­sis, frag­men­ta­tion of care, and mor­tal­i­ty across Chica­go, Illi­nois. Di­a­betes Care 2016;39:1671– 1676
183. Gar­vey KC, Fos­ter NC, Agar­w­al S, etal. Health care tran­si­tion prepa­ra­tion and ex­pe­ri­ences in a U.S. na­tion­al sam­ple of young adults with type 1 di­a­betes. Di­a­betes Care 2017;40:317–324
184. The En­docrine So­ci­ety. Man­ag­ing the tran­si­tion of care for pa­tients with type 1 di­a­betes [In­ter­net]. Avail­able from https://www.en­docrine.org/guide­lines-and-clin­i­cal-prac­tice/ qual­i­ty-im­provement-re­sources/clin­i­cal-prac­ticere­sources/ tran­si­tion-‍of-‍care. Ac­cessed 16 Oc­to­ber 2018